Jonathan Rubin - 23 Feb 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: SVP, Chief Medical Officer
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol: SUPN
Transactions as of: 23 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Feb 2023, 16:03:50 UTC
Previous filing: 24 Feb 2023
Next filing: 18 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						2,497	23 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Employee Stock Option (Right to Buy)	Award	$0	+20,000		$0.000000	20,000	23 Feb 2023	Common Stock	20,000	$38.60	Direct	F1
transaction	SUPN	Restricted Stock Units	Award	$0	+5,000		$0.000000	5,000	23 Feb 2023	Common Stock	5,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in four equal annual installments beginning on February 23, 2024.
F2	Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3	These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024.